2-[(E)-2-(2,1,3-benzothiadiazol-5-yl)ethenyl]-3-[3-(trifluoromethyl)phenyl]quinazolin-4-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-[(E)-2-(2,1,3-benzothiadiazol-5-yl)ethenyl]-3-[3-(trifluoromethyl)phenyl]quinazolin-4-one
• 化学式: C₂₃H₁₃F₃N₄OS
• 分子量: 450.4
• InChiKey: MMEKZQGYMQTBLD-PKNBQFBNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  32
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  86.7
• 氢给体数：
  0
• 氢受体数：
  8

文献信息

• DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER
  申请人：COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

  公开号：US20150175556A1

  公开（公告）日：2015-06-25

  The invention relates to novel dihydropyrimidin-2(1H)-ones and dihydropyrimidin-2(1H)-thiones of formula (Ia): The invention also relates to the use of such compounds as medicaments, and in particular as inhibitors of sodium iodide symporter (NIS) and reducers of iodine transport and/or accumulation into NIS expressing cells. The invention also concerns a pharmaceutical composition comprising at least one compound of formula (Ia) as active principle.

  本发明涉及一种新型二氢嘧啶-2(1H)-酮和二氢嘧啶-2(1H)-硫酮，化学式为(Ia)。本发明还涉及将这些化合物用作药物，特别是作为钠碘共转运体(NIS)的抑制剂和减少碘在表达NIS的细胞中的运输和/或积累的药物。本发明还涉及一种包含至少一种化合物(Ia)作为活性成分的药物组合物。
• Heterocyclic Compounds As Inhibitors Of The Sodium Iodide Symporter
  申请人：COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

  公开号：US20150299218A1

  公开（公告）日：2015-10-22

  The invention relates to new compounds of formula (I): for their use as medicaments, for inhibiting sodium iodide symporter (NIS), and in particular for reducing iodine transport and/or accumulation into NIS-expressing cells. The invention also relates to a pharmaceutical composition having at least one compound of formula (I) as active principle. Finally, the present invention relates to specific compounds of formula (I) as such.

  本发明涉及化合物的新公式（I）：用作药物，用于抑制钠碘共转运体（NIS），尤其用于减少碘在表达NIS的细胞中的转运和/或积累。本发明还涉及具有至少一种公式（I）化合物作为活性成分的制药组合物。最后，本发明涉及公式（I）的特定化合物本身。